Related references
Note: Only part of the references are listed.The signaling role for chloride in the bidirectional communication between neurons and astrocytes
Corinne S. Wilson et al.
NEUROSCIENCE LETTERS (2019)
Suppression of inflammation and acquired immunity by IL-37
Giulio Cavalli et al.
IMMUNOLOGICAL REVIEWS (2018)
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)
Desiree van der Heijde et al.
JOURNAL OF RHEUMATOLOGY (2018)
Chemokines CXCL10, CXCL11, and CXCL13 in acute disseminated encephalomyelitis, non-polio enterovirus aseptic meningitis, and neuroborreliosis: CXCL10 as initial discriminator in diagnostic algorithm?
Lorna Stemberger Maric et al.
NEUROLOGICAL SCIENCES (2018)
Safety and efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: a randomized, placebo-controlled, ascending-dose study
O. Nemoto et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Safety and Efficacy of Reslizumab for Children and Adolescents With Eosinophilic Esophagitis Treated for 9 Years
Jonathan E. Markowitz et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Emma Guttman-Yassky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study
Joan T. Merrill et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis
Gerd R. Burmester et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
Nirmala Chandralega Kampan et al.
CURRENT MEDICINAL CHEMISTRY (2018)
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
Jeffrey S. Miller et al.
CLINICAL CANCER RESEARCH (2018)
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
Kenneth F. Baker et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Designing small molecule CXCR3 antagonists
James E. Pease
EXPERT OPINION ON DRUG DISCOVERY (2017)
TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology
Francoise Meylan et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Novel TGF-β inhibitors ready for prime time in onco-immunology
Armand de Gramont et al.
ONCOIMMUNOLOGY (2017)
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy
Federica Furfaro et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Type I interferon pathway in CNS homeostasis and neurological disorders
Thomas Blank et al.
GLIA (2017)
Mechanisms of Regulation of the Chemokine-Receptor Network
Martin J. Stone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Dendritic cell recruitment and activation in autoimmunity
Silvano Sozzani et al.
JOURNAL OF AUTOIMMUNITY (2017)
Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases
Massimo Gadina et al.
JOURNAL OF AUTOIMMUNITY (2017)
Mucosal Chemokines
Marcela Hernandez-Ruiz et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2017)
Can we design a better anti-cytokine therapy?
Marina S. Drutskaya et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
CXCL11 production in cerebrospinal fluid distinguishes herpes simplex meningitis from herpes simplex encephalitis
Liza Lind et al.
JOURNAL OF NEUROINFLAMMATION (2017)
The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis
Sambor Grygorczuk et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Long-term outcomes of refractory neurosarcoidosis treated with infliximab
Fleur Cohen Aubart et al.
JOURNAL OF NEUROLOGY (2017)
CXCR4 Ligands: The Next Big Hit?
Annemiek M. E. Walenkamp et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
TNF-alpha inhibitor associated myelopathies: A neurological complication in patients with rheumatologic disorders
Paula Barreras et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Cerebrospinal Fluid NLRP3 is Increased After Severe Traumatic Brain Injury in Infants and Children
Jessica S. Wallisch et al.
NEUROCRITICAL CARE (2017)
Infliximab for the treatment of CNS sarcoidosis A multi-institutional series
Jeffrey M. Gelfand et al.
NEUROLOGY (2017)
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
Marta Miralles et al.
NEUROTHERAPEUTICS (2017)
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
I. D. Pavord et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Trial of Tocilizumab in Giant-Cell Arteritis
J. H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma
Parameswaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
First Pediatric Patient With Neuromyelitis Optica and Sjögren Syndrome Successfully Treated With Tocilizumab
Achille Marino et al.
PEDIATRIC NEUROLOGY (2017)
Methodological and Ethical Issues in Pediatric Medication Safety Research
Delesha Carpenter et al.
PEDIATRICS (2017)
A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6
Remy Robert et al.
PLOS ONE (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Should We Stop Saying 'Glia' and 'Neuroinflammation'?
Roser Masgrau et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Introduction
Michael R. Pranzatelli
SEMINARS IN PEDIATRIC NEUROLOGY (2017)
Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping
Bibiana Bielekova et al.
SEMINARS IN PEDIATRIC NEUROLOGY (2017)
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
Limin Song et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Role of Atypical Chemokine Receptors in Microglial Activation and Polarization
Valentina Salvi et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Whole-cell cholera vaccines provide little protection to children
[Anonymous]
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Tocilizumab (Actemra)
Martin Sheppard et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Cerebrospinal Fluid Cytokines Correlate With Aseptic Meningitis and Blood-Brain Barrier Function in Neonatal-Onset Multisystem Inflammatory Disease: Central Nervous System Biomarkers in Neonatal-Onset Multisystem Inflammatory Disease Correlate With Central Nervous System Inflammation
Jackeline Rodriguez-Smith et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
William Stohl et al.
ARTHRITIS & RHEUMATOLOGY (2017)
CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis
Anna Pittaluga
FRONTIERS IN IMMUNOLOGY (2017)
Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
Timur Khaibullin et al.
FRONTIERS IN IMMUNOLOGY (2017)
Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness
Sara Guerreiro Castro et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2017)
Dengue virus and Japanese encephalitis virus infection of the central nervous system share similar profiles of cytokine accumulation in cerebrospinal fluid
Haipeng Li et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Cytokine networks in neuroinflammation
Burkhard Becher et al.
NATURE REVIEWS IMMUNOLOGY (2017)
A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain
Kuo-Jen Wu et al.
CELL TRANSPLANTATION (2017)
Chemokine and cytokine levels in the lumbar cerebrospinal fluid of preterm infants with post-hemorrhagic hydrocephalus
Gakwaya Habiyaremye et al.
FLUIDS AND BARRIERS OF THE CNS (2017)
The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation
Stefan Rose-John
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Drugging the 'undruggable' cancer targets
Chi V. Dang et al.
NATURE REVIEWS CANCER (2017)
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial
Tatsuya Atsumi et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome
Inna S. Afonina et al.
NATURE IMMUNOLOGY (2017)
Brodalumab: the first anti- IL-17 receptor agent for psoriasis
L. Puig
DRUGS OF TODAY (2017)
The innate immune system in human systemic lupus erythematosus
Marc Weidenbusch et al.
CLINICAL SCIENCE (2017)
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
Kevin C. Kemp et al.
ANNALS OF NEUROLOGY (2017)
B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis
Alexander Schwarz et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE)
Kenneth C. Kalunian et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis
Puneet Dixit et al.
INFLAMMATION RESEARCH (2016)
Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases
Michela Silacci et al.
MABS (2016)
Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial
Tsutomu Takeuchi et al.
MODERN RHEUMATOLOGY (2016)
In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity
Pervinder Sagoo et al.
NATURE MEDICINE (2016)
Successes and failures of chemokine-pathway targeting in rheumatoid arthritis
Zoltan Szekanecz et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
George D. Kalliolias et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
In Vivo Imaging of Human Neuroinflammation
Daniel S. Albrecht et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Febrile Infection-Related Epilepsy Syndrome Treated with Anakinra
Daniel L. Kenney-Jung et al.
ANNALS OF NEUROLOGY (2016)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein
Spencer Ng et al.
CANCER RESEARCH (2016)
Minimalist Antibodies and Mimetics: An Update and Recent Applications
Virginia J. Bruce et al.
CHEMBIOCHEM (2016)
Early BAFF receptor blockade mitigates murine Sjogren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction
Arjun Sharma et al.
CLINICAL IMMUNOLOGY (2016)
CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review
Kavitha Kothur et al.
CYTOKINE (2016)
Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study
Stanislas Lagarde et al.
EPILEPSIA (2016)
i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4
Katherine Griffiths et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Cytokine and Chemokine Expression in CSF May Differentiate Viral and Autoimmune NMDAR Encephalitis in Children
Sofia Ygberg et al.
JOURNAL OF CHILD NEUROLOGY (2016)
New feasible treatment for refractory autoimmune encephalitis: Low-dose interleukin-2
Jung-Ah Lim et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells
Chen-Yen Chung et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
Zuzana Liba et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Neuroimmune Mechanisms in
Gregory B. Potter et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2016)
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B
Sergio M. de Almeida et al.
JOURNAL OF NEUROVIROLOGY (2016)
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders
Christine Lebrun et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus
T. Yoshio et al.
LUPUS (2016)
Interferon-targeted therapy in systemic lupus erythematosus: Is this an alternative to targeting B and T cells?
K. C. Kalunian
LUPUS (2016)
Clinical Value of Assessing Cytokine Levels for the Differential Diagnosis of Bacterial Meningitis in a Pediatric Population
Qing Ye et al.
MEDICINE (2016)
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV
Guillaume Martin-Blondel et al.
NATURE REVIEWS NEUROLOGY (2016)
The BAFFling effects of rituximab in lupus: danger ahead?
Michael R. Ehrenstein et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
Woo-Jin Lee et al.
NEUROTHERAPEUTICS (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Biomarkers in Cerebrospinal Fluid of Children With Tick-borne Encephalitis: Association With Long-term Outcome
Asa Fowler et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Cerebrospinal fluid cytokines in the diagnosis of bacterial meningitis in infants
Lakshmi Srinivasan et al.
PEDIATRIC RESEARCH (2016)
Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis
Kavitha Kothur et al.
PLOS ONE (2016)
Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma
Esa Jantunen et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
Kathryn A. Thibert et al.
SCIENTIFIC REPORTS (2016)
The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis
Philip J. Mease et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
Nicola A. Hanania et al.
LANCET RESPIRATORY MEDICINE (2016)
Modulation of Chemokine Responses: Synergy and Cooperativity
Amanda E. I. Proudfoot et al.
FRONTIERS IN IMMUNOLOGY (2016)
The role of IL-17 in CNS diseases
Ari Waisman et al.
ACTA NEUROPATHOLOGICA (2015)
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease
B. G. Feagan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
A Destructive Feedback Loop Mediated by CXCL10 in Central Nervous System Inflammatory Disease
Wendy K. Roberts et al.
ANNALS OF NEUROLOGY (2015)
CXCL13 antibody for the treatment of autoimmune disorders
Ekaterina Klimatcheva et al.
BMC IMMUNOLOGY (2015)
An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15
Francoise Bachelerie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia
Carlos Cuesta-Mateos et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Interleukin-6 as a Therapeutic Target
Jean-Francois Rossi et al.
CLINICAL CANCER RESEARCH (2015)
Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease
Corey Casper et al.
CLINICAL CANCER RESEARCH (2015)
Stratified medicine in inflammatory disorders: From theory to practice
Joseph R. Amon et al.
CLINICAL IMMUNOLOGY (2015)
Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases
Kunihiro Ichinose et al.
CLINICAL IMMUNOLOGY (2015)
The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials
Mary Jane Welch et al.
CLINICAL TRIALS (2015)
The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
Christoph Garbers et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Targeting chemokines: Pathogens can, why can't we?
Amanda E. I. Proudfoot et al.
CYTOKINE (2015)
Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease
Lin Sun et al.
CYTOKINE (2015)
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Itay Raphael et al.
CYTOKINE (2015)
Targeting chemokine receptors in disease - a case study of CCR4
Roberto Solari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential
John A. Hamilton
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
Has CXCL13 an Added Value in Diagnosis of Neurosyphilis?
Khutso M. Mothapo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis
Philippe Horellou et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain
Hao Kang et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Cerebrospinal fluid Th1/Th2 cytokine profiles in children with enterovirus 71-associated meningoencephalitis
Huajun Li et al.
MICROBIOLOGY AND IMMUNOLOGY (2015)
Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses
Jeanine R. Jarness Utz et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Subclinical central inflammation is risk for RIS and CIS conversion to MS
S. Rossi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Dealing with Danger in the CNS: The Response of the Immune System to Injury
Sachin P. Gadani et al.
NEURON (2015)
IL-6 regulation of synaptic function in the CNS
Donna L. Gruol
NEUROPHARMACOLOGY (2015)
Neuroinflammation: Ways in Which the Immune System Affects the Brain
Richard M. Ransohoff et al.
NEUROTHERAPEUTICS (2015)
Siltuximab (CNTO 328): a promising option for human malignancies
Runzhe Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents
Aleksander Lenert et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
A strategy to discover decoy chemokine ligands with an anti-inflammatory activity
Dayana Abboud et al.
SCIENTIFIC REPORTS (2015)
Viral diseases of the central nervous system
Phillip A. Swanson et al.
CURRENT OPINION IN VIROLOGY (2015)
Investigations on CXCL13 in Anti-N-Methyl-D-Aspartate Receptor Encephalitis A Potential Biomarker of Treatment Response
Frank Leypoldt et al.
JAMA NEUROLOGY (2015)
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein et al.
JAMA NEUROLOGY (2015)
Subclinical central inflammation is risk for RIS and CIS conversion to MS
S. Rossi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis A Randomized Phase IIa Trial
Ladislav Senolt et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Pharmaceutical aspects of anti-inflammatory TNF-blocking drugs
Sandhya Jinesh
INFLAMMOPHARMACOLOGY (2015)
Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab
Xiao Ni et al.
ONCOIMMUNOLOGY (2015)
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
R. A. Furie et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease
Cailin H. Sibley et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
CXCL10/XCL1 fusokine elicits in vitro and in vivo chemotaxis
Yessica E. Sanchez-Lugo et al.
BIOTECHNOLOGY LETTERS (2015)
Analysis of IL-6/gp130 Family Receptor Expression Reveals That in Contrast to Astroglia, Microglia Lack the Oncostatin M Receptor and Functional Responses to Oncostatin M
Meng-Ping Hsu et al.
GLIA (2015)
Concise Review: Engineering the Fusion of Cytokines for the Modulation of Immune Cellular Responses in Cancer and Autoimmune Disorders
Spencer Ng et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Update on biomarkers in neuromyelitis optica
Esther Melamed et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
Yen Chih Lin et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Targeting CXCL13 During Neuroinflammation
Amanda K. Huber et al.
ADVANCES IN NEUROIMMUNE BIOLOGY (2015)
IFN-γ for Friedreich ataxia: present evidence
McKenzie Wells et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2015)
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis
Cris S. Constantinescu et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis
R. Dersch et al.
FLUIDS AND BARRIERS OF THE CNS (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases
Alessandro Antonelli et al.
AUTOIMMUNITY REVIEWS (2014)
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis
Sarah E. Blink et al.
CELLULAR IMMUNOLOGY (2014)
Cytokine networking of innate immunity cells: a potential target of therapy
Ilja Striz et al.
CLINICAL SCIENCE (2014)
T Helper Cells Plasticity in Inflammation
Lorenzo Cosmi et al.
CYTOMETRY PART A (2014)
Flow Cytometry Applications for the Analysis of Chemokine Receptor Expression and Function
Achille Anselmo et al.
CYTOMETRY PART A (2014)
Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists
Laura Ajram et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases
Remo C. Russo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Lloyd Mayer et al.
GUT (2014)
Immunotherapy of B-cell non-Hodgkin lymphoma by targeting the chemokine receptor CXCR5 in a preclinical mouse model
Hossein Panjideh et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
A Soluble Form of IL-27Rα Is a Natural IL-27 Antagonist
Celine Dietrich et al.
JOURNAL OF IMMUNOLOGY (2014)
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome
Rotem Orbach et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
Cerebrospinal Fluid TNF-alpha, IL-6, and IL-8 in Children With Bacterial Meningitis
Rajniti Prasad et al.
PEDIATRIC NEUROLOGY (2014)
Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers
Jessica L. Williams et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Classification of current anticancer immunotherapies
Lorenzo Galluzzi et al.
ONCOTARGET (2014)
Infectome: A platform to trace infectious triggers of autoimmunity
Dimitrios P. Bogdanos et al.
AUTOIMMUNITY REVIEWS (2013)
Atypical chemokine receptors: from silence to sound
Cinzia Cancellieri et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis
Leonam G. Coutinho et al.
BMC INFECTIOUS DISEASES (2013)
Expression of CXCR3 and its ligands CXCL9,-10 and-11 in paediatric opsoclonusmyoclonus syndrome
M. R. Pranzatelli et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Diagnostic Value of Cytokines and Chemokines in Lyme Neuroborreliosis
T. Cerar et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
A review of phase II trial designs for initial marker validation
Sumithra J. Mandrekar et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Neuron-Microglia Interaction in Neuroinflammation
Akio Suzumura
CURRENT PROTEIN & PEPTIDE SCIENCE (2013)
Emerging role of interleukin-22 in autoimmune diseases
Hai-Feng Pan et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
The Interleukin-1 Family: Back to the Future
Cecilia Garlanda et al.
IMMUNITY (2013)
Virus infection, antiviral immunity, and autoimmunity
Daniel R. Getts et al.
IMMUNOLOGICAL REVIEWS (2013)
Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function
Christophe Blanchetot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Pediatric Reference Ranges for Proinflammatory and Anti-Inflammatory Cytokines in Cerebrospinal Fluid and Serum by Multiplexed Immunoassay
Michael R. Pranzatelli et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
Isabell Hamann et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
Michael R. Pranzatelli et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders
Michael R. Pranzatelli et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions
Enrique Alvarez et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
The Causative Pathogen Determines the Inflammatory Profile in Cerebrospinal Fluid and Outcome in Patients with Bacterial Meningitis
Denis Grandgirard et al.
MEDIATORS OF INFLAMMATION (2013)
Elevation of proinflammatory cytokines in patients with Aicardi-Goutieres syndrome
Asako Takanohashi et al.
NEUROLOGY (2013)
A Role for the CXCR3/CXCL10 Axis in Rasmussen Encephalitis
Isabel Mirones et al.
PEDIATRIC NEUROLOGY (2013)
Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis
Keith R. Edwards et al.
PLOS ONE (2013)
B-cell targeted therapeutics in clinical development
Stephan Blueml et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Th1 and Th17 but no Th2-related cytokine spectrum in the cerebrospinal fluid of children with Borrelia-related facial nerve palsy
Zuzana Liba et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
Daclizumab Use in Patients With Pediatric Multiple Sclerosis
Mark P. Gorman et al.
ARCHIVES OF NEUROLOGY (2012)
Cellular Immune Suppression in Paraneoplastic Neurologic Syndromes Targeting Intracellular Antigens
Dana Orange et al.
ARCHIVES OF NEUROLOGY (2012)
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
Michael Yellin et al.
ARTHRITIS AND RHEUMATISM (2012)
Pharmacological modulation of chemokine receptor function
D. J. Scholten et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis
Aimin Wu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppression
Craig J. Smith et al.
CYTOKINE (2012)
Innate immunity in the central nervous system
Richard M. Ransohoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
CCR2+CCR5+ T Cells Produce Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis
Wakiro Sato et al.
JOURNAL OF IMMUNOLOGY (2012)
A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis
Kenneth B. Gordon et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS
Michael R. Pranzatelli et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barre Syndrome
Shujuan Li et al.
MEDIATORS OF INFLAMMATION (2012)
Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients
Michael Rentzos et al.
NEUROLOGICAL RESEARCH (2012)
Characterization of 99mTc-labeled cytokine ligands for inflammation imaging via TNF and IL-1 pathways
Zhonglin Liu et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity
Troy C. Lund et al.
PLOS ONE (2012)
Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation
Bibiana Bielekova et al.
PLOS ONE (2012)
CXCL13 chemokine in pediatric and adult neuroborreliosis
N. Wutte et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
The blood-brain barrier, chemokines and multiple sclerosis
David W. Holman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children
Yoshinori Ito et al.
CYTOKINE (2011)
Probing cytokines, chemokines and matrix metalloproteinases towards better immunotherapies of multiple sclerosis
Ghislain Opdenakker et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid
N. D. van Burgel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
GM-CSF-Based Fusion Cytokines as Ligands for Immune Modulation
Patrick Williams et al.
JOURNAL OF IMMUNOLOGY (2011)
Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study
Anna J. Henningsson et al.
JOURNAL OF NEUROINFLAMMATION (2011)
A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
Roman Fischer et al.
PLOS ONE (2011)
Enhanced expression of cytokines/chemokines in cerebrospinal fluids in mumps meningitis in children
Takeshi Asano et al.
PEDIATRICS INTERNATIONAL (2011)
Monoclonal antibodies for the treatment of asthma
Matthew C. Catley et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Canakinumab (ACZ885, a fully human IgG1 anti-IL-1 beta mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)
Jasmin B. Kuemmerle-Deschner et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults
Jeffrey M. Jacobson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market
Chung-Jr Huang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis
Oemer Faruk Aydin et al.
BRAIN & DEVELOPMENT (2010)
GPCR signalling to the translation machinery
Astrid Musnier et al.
CELLULAR SIGNALLING (2010)
Mechanisms of injury in bacterial meningitis
Joachim Gerber et al.
CURRENT OPINION IN NEUROLOGY (2010)
CCR1 Antagonists: What Have We Learned From Clinical Trials
Ronald P. Gladue et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
IL-17 is elevated in cerebrospinal fluids in bacterial meningitis in children
Takeshi Asano et al.
CYTOKINE (2010)
Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
J. Mellergard et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Akiyuki Uzawa et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Cytokines and chemokines in viral encephalitis: A clinicoradiological correlation
Jayantee Kalita et al.
NEUROSCIENCE LETTERS (2010)
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
Johannes Brettschneider et al.
PLOS ONE (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Gwendal Lazennec et al.
TRENDS IN MOLECULAR MEDICINE (2010)
CCR5: From Natural Resistance to a New Anti-HIV Strategy
Lucia Lopalco
VIRUSES-BASEL (2010)
Serum sickness, encephalitis and other complications of anti-cytokine therapy
Severine Vermeire et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2009)
Engineered protein scaffolds as next-generation antibody therapeutics
Michaela Gebauer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
A substantial number of Rasmussen syndrome patients have increased IgG, CD4(+) T cells, TNF alpha, and Granzyme B in CSF
Yukitoshi Takahashi et al.
EPILEPSIA (2009)
Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome
Kazuhiro Haginoya et al.
EPILEPSY RESEARCH (2009)
Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology
Richard M. Ransohoff
IMMUNITY (2009)
Detection of MCP-1 and IL-8 in the serum and cerebrospinal fluid of a child with Miller Fisher syndrome
Satoshi Sato et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Selective Inhibition of CCR2 Expressing Lymphomyeloid Cells in Experimental Autoimmune Encephalomyelitis by a GM-CSF-MCP1 Fusokine
Moutih Rafei et al.
JOURNAL OF IMMUNOLOGY (2009)
Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response
Adrian Liston et al.
JOURNAL OF IMMUNOLOGY (2009)
Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome
V. Fuehlhuber et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
F. Sellebjerg et al.
NEUROLOGY (2009)
An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
Ivona Aksentijevich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Interleukin-6 in neuro-Behcet's disease: Association with disease subsets and long-term outcome
Guelsen Akman-Demir et al.
CYTOKINE (2008)
Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutieres syndrome
Jane T. van Heteren et al.
GLIA (2008)
A New Approach to the Blocking of Alloreactive T Cell-Mediated Graft-versus-Host Disease by In Vivo Administration of Anti-CXCR3 Neutralizing Antibody
Shan He et al.
JOURNAL OF IMMUNOLOGY (2008)
Lymphoid chemokines in chronic neuroinflammation
Francesca Aloisi et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Sjogren's syndrome-associated meningoencephalomyelitis: Cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus
Takayuki Hoshina et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M. Segal et al.
LANCET NEUROLOGY (2008)
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis
M. Tanaka et al.
NEUROLOGY (2008)
Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: Effects of moderate hypothermia
Sandra D. W. Buttram et al.
JOURNAL OF NEUROTRAUMA (2007)
APC-derived cytokines and T cell polarization in autoimmune inflammation
Ilona Gutcher et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus
H. Fragoso-Loyo et al.
ARTHRITIS AND RHEUMATISM (2007)
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis
Diego Franciotta et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis
Naoyuki Tanuma et al.
ACTA NEUROPATHOLOGICA (2006)
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
Jasper J. Haringman et al.
ARTHRITIS AND RHEUMATISM (2006)
Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea
T Ichiyama et al.
CYTOKINE (2006)
CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis
Takaaki Ishizu et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Chemokine receptors as biomarkers in multiple sclerosis
Robert J. Fox et al.
DISEASE MARKERS (2006)
Chemokine blockers - therapeutics in the making?
TNC Wells et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Cerebrospinal fluid interleukin-6 levels in patients with West syndrome
H Tekgul et al.
BRAIN & DEVELOPMENT (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis
G Saruhan-Direskeneli et al.
CYTOKINE (2005)
The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis
TA Rupprecht et al.
NEUROLOGY (2005)
Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae
M Narita et al.
PEDIATRIC NEUROLOGY (2005)
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
L Cartier et al.
BRAIN RESEARCH REVIEWS (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Expression of CCR7 in multiple sclerosis:: Implications for CNS immunity
P Kivisäkk et al.
ANNALS OF NEUROLOGY (2004)
Development of biomarkers in multiple sclerosis
B Bielekova et al.
BRAIN (2004)
Experience with immunomodulatory treatments in Rasmussen's encephalitis
T Granata et al.
NEUROLOGY (2003)
CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?
AJ Church et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
DJ Mahad et al.
SEMINARS IN IMMUNOLOGY (2003)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology
RR Neubig et al.
PHARMACOLOGICAL REVIEWS (2003)
Interleukin-1β, tumor necrosis factor-α, and nitrite levels in febrile seizures
S Haspolat et al.
JOURNAL OF CHILD NEUROLOGY (2002)
Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis
M Grusell et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation:: implications for CNS trafficking
P Kivisäkk et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Multiple sclerosis and optic neuritis:: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid
N Teleshova et al.
JOURNAL OF NEUROLOGY (2002)
Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections
M Pashenkov et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist
WF Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis
DR Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Virus-induced autoimmunity: Potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease
JK Olson et al.
VIRAL IMMUNOLOGY (2001)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Share Paper
